“…Assessments were identical at baseline and at 3-year follow-up and included: (1) demographic and clinical information obtained from the clinical records of the patients (clinical course and specific characteristics of BD, psychiatric and physical comorbidities, officially recognized disability, and psychopharmacological treatments); (2) psychometric assessment: (2a) clinician-rated outcome measures (CROMs): Spanish versions of Hamilton Depression Rating Scale (HDRS) 23 , Hamilton Anxiety Rating Scale (HARS) 24 , Young Mania Rating Scale (YMRS) 25 , Clinical Global Impression (CGI) 26 , Oviedo Sleep Questionnaire (OSQ) 27 , Changes in Sexual Functioning Questionnaire (CSFQ) 28 , Scale for Cognitive Impairment in Psychiatry (SCIP) 29 , Global Assessment of Functioning (GAF) 30 , lipid profile (cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), glucose, hepatic function (GPT, GOT, GGT, bilirubin), renal function (creatinine, BUN), hormones (PRL, TSH), and inflammatory and oxidative biomarkers (CRP, homocysteine)] were collected (for further detail, see Fuente-Tomas et al 21 ).…”